Your browser doesn't support javascript.
Deubiquitinases: From mechanisms to their inhibition by small molecules.
Lange, Sven M; Armstrong, Lee A; Kulathu, Yogesh.
  • Lange SM; MRC Protein Phosphorylation & Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.
  • Armstrong LA; MRC Protein Phosphorylation & Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.
  • Kulathu Y; MRC Protein Phosphorylation & Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK. Electronic address: ykulathu@dundee.ac.uk.
Mol Cell ; 82(1): 15-29, 2022 01 06.
Article in English | MEDLINE | ID: covidwho-1525902
ABSTRACT
Deubiquitinases (DUBs) are specialized proteases that remove ubiquitin from substrates or cleave within ubiquitin chains to regulate ubiquitylation and therefore play important roles in eukaryotic biology. Dysregulation of DUBs is implicated in several human diseases, highlighting the importance of DUB function. In addition, many pathogenic bacteria and viruses encode and deploy DUBs to manipulate host immune responses and establish infectious diseases in humans and animals. Hence, therapeutic targeting of DUBs is an increasingly explored area that requires an in-depth mechanistic understanding of human and pathogenic DUBs. In this review, we summarize the multiple layers of regulation that control autoinhibition, activation, and substrate specificity of DUBs. We discuss different strategies to inhibit DUBs and the progress in developing selective small-molecule DUB inhibitors. Finally, we propose a classification system of DUB inhibitors based on their mode of action.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Enzyme Inhibitors / Ubiquitination / Deubiquitinating Enzymes / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Mol Cell Journal subject: Molecular Biology Year: 2022 Document Type: Article Affiliation country: J.molcel.2021.10.027

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Enzyme Inhibitors / Ubiquitination / Deubiquitinating Enzymes / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Mol Cell Journal subject: Molecular Biology Year: 2022 Document Type: Article Affiliation country: J.molcel.2021.10.027